|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-induced persistent activation of NF-
B through phosphorylation of I-
B
1 Vascular Biology Unit, Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, United States
* To whom correspondence should be addressed. E-mail: bjiang{at}bu.edu.
Activation of NF-
B requires the phosphorylation and degradation of its associated inhibitory proteins I-
B. Previously we reported that the extracellular signal-regulated kinase (ERK) is required for interleukin-1
to induce persistent activation of NF-
B in cultured rat vascular smooth muscle cells (VSMCs). The present study examined the mechanism by which the ERK signaling cascade modulates the duration of NF-
B activation. In cultured rat VSMCs, interleukin-1
activated ERK and induced degradation of both I-
B
and I-
B
, which was associated with nuclear translocation of both ribosomal S6 kinase (RSK)-1 and NF-
B p65. RSK1, a downstream kinase of ERK, was associated with an I-
B
/NF-
B complex, which was independent of the phosphorylation status of RSK1. Treatment of VSMCs with interleukin-1
decreased I-
B
in the RSK1/I-
B
/NF-
B complex, an effect that was attenuated by inhibition of ERK activation. Knockdown of RSK1 by small interference RNA attenuated the IL-1
-induced I-
B
decrease without influencing ether ERK phosphorylation or the earlier I-
B
degradation. By using recombinant wild type and mutant I-
B
proteins, both active ERK2 and RSK1 were found to directly phosphorylate I-
B
, but only active RSK1 phosphorylated I-
B
on Ser19 and Ser23, two sites known to mediate the subsequent ubiquitination and degradation. In conclusion, in the ERK signaling cascade, RSK1 is a key component that directly phosphorylates I-
B
and contributes to the persistent activation of NF-
B by IL-1
.
This article has been cited by other articles:
![]() |
T. M. Lindstrom, A. R. Mohan, M. R. Johnson, and P. R. Bennett Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells Mol. Pharmacol., July 1, 2008; 74(1): 109 - 121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |